AyurMaya Capital Management Company, LP
Long book
$333.5M
Q1 2026
Positions
1
Top-10 weight
100%
concentration
Last quarter
+125.7%
SPY -4.4%
Turnover
0%
of book per quarter
Strategy in plain words
auto-generated from filingsAyurMaya Capital Management Company, LP is a diversified fundamental manager, specialised in healthcare (100% of the long book), running a $333.5M US long book across 1 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: ALUMIS INC.
Over the last 7 quarters its long book ran on average 23.3pp per quarter ahead of the S&P 500, beating the index in 3 of 7 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q2 2024
-19.7%
Q3 2024
-26.4%
Q4 2024
-21.9%
Q1 2025
-51.1%
Q2 2025
+33.0%
Q3 2025
+144.6%
Q4 2025
+125.7%
Sector allocation
Healthcare 100%
Long book by quarter
What does AyurMaya Capital own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| ALMS ALUMIS INC | Healthcare | 15.1M | $333.5M | 100.0% | 0.0% |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | Aug 12, 2026 | 1 | $333.5M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 1 | $147.8M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 13, 2025 | 1 | $60.4M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 1 | $45.4M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 14, 2025 | 2 | $88.4M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 13, 2025 | 2 | $113.0M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 14, 2024 | 2 | $159.7M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 2 | $182.8M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 1 | $63.0M | canonical | SEC ↗ |